KR920002595A - 테트라히드로 피리디닐디벤즈 아제핀 유도체 - Google Patents

테트라히드로 피리디닐디벤즈 아제핀 유도체 Download PDF

Info

Publication number
KR920002595A
KR920002595A KR1019910012570A KR910012570A KR920002595A KR 920002595 A KR920002595 A KR 920002595A KR 1019910012570 A KR1019910012570 A KR 1019910012570A KR 910012570 A KR910012570 A KR 910012570A KR 920002595 A KR920002595 A KR 920002595A
Authority
KR
South Korea
Prior art keywords
derivative
pharmaceutically acceptable
acceptable salt
sulfur
lower alkyl
Prior art date
Application number
KR1019910012570A
Other languages
English (en)
Inventor
케이른스 제임스.
조오지 기브슨 사무엘
칸 로버슨 래 둔
Original Assignee
에프.지.엠.헤르 만스·에이.지.제이. 베르 메렌
악조 엔. 브이
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 에프.지.엠.헤르 만스·에이.지.제이. 베르 메렌, 악조 엔. 브이 filed Critical 에프.지.엠.헤르 만스·에이.지.제이. 베르 메렌
Publication of KR920002595A publication Critical patent/KR920002595A/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurosurgery (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyrrole Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

내용 없음

Description

테트라히드로 피리디닐디벤즈 아제핀 유도체
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (7)

  1. 하기 일반식(Ⅰ)의 테트라히드로 피리디닐디벤즈아제핀 유도체 또는 그 약학적 허용염,
    상기식에서, R1은 수소, 할로겐 및 저급알킬로 이루어진 군중에서 선택된 치환체이도, R2는 수소, 저급알킬, 저급알케닐, 히드록시 치한된 저급알킬 또는 히드록시 치환된 저급알케닐로 이루어진 군중에서 선택되고, X는 산소, 황 또는 CH2이고, Y는 HC=CH 또는 황임.
  2. 제1항에 있어서, R1은 염소, 취소 또는 에틸이고, R2는 메틸 또는 에틸인 것을 특징으로 하는 테트라히드로 피리디닐디벤즈아제핀 유도체 또는 그 약학적 허용염.
  3. 제1항 또는 제2항에 있어서, Y는 HC=CH 이고 X는 황이거나, Y는 황이고 X는 CH2인 것을 특징으로 하는 테트라히드로피리디닐디벤즈아제핀 유도체 또는 그 약학적 허용염.
  4. 제1항에 있어서, R1은 염소이고, R2는 메틸이고, X는 황이고, Y는 HC=CH인 것을 특징으로 하는 테트라히드로피리디닐벤즈아제핀 유도체 또는 그 약학적 허용염.
  5. 제1항의 테트라히드로 피리디닐디벤즈 아제핀의 제조방법에 있어서, a)하기 일반식(Ⅱ)의 아미드를 고리화시키거나, b)하기 일반식(Ⅲ)의 이미도일 할라이드를 고리화시키거나, c)하기 일반식(Ⅳ)의 피리디늄 유도체를 환원시키고, 이어서 수득생성물을 약학적 허용염으로 임의로 전환시키는 것을 특징으로 하는 방법.
    상기식에서 R1,R2,X 및 Y는 제1항 내지 제4항중 어느 한항에 있어서서 정의한 바와 같고, Hal은 할라이드를 나타내고 Z는 이탈기임.
  6. 제1항의 테트라히드로피리디닐 디벤조 아제핀 유도체와 함께 약학적 허용부형제를 함유하는 약학학제. 연 합할상표 상표등록 제110,525호.
  7. 정신질환 치료용 약물제조에 제1항에 테트라히드로피리디닐 디벤조 아제핀 유도체를 사용하는 방법.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019910012570A 1990-07-24 1991-07-23 테트라히드로 피리디닐디벤즈 아제핀 유도체 KR920002595A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP90.308.0711 1990-07-24
EP90308071 1990-07-24

Publications (1)

Publication Number Publication Date
KR920002595A true KR920002595A (ko) 1992-02-28

Family

ID=8205498

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019910012570A KR920002595A (ko) 1990-07-24 1991-07-23 테트라히드로 피리디닐디벤즈 아제핀 유도체

Country Status (13)

Country Link
EP (1) EP0468562B1 (ko)
JP (1) JPH04234384A (ko)
KR (1) KR920002595A (ko)
AT (1) ATE98240T1 (ko)
AU (1) AU640799B2 (ko)
CA (1) CA2046488A1 (ko)
DE (1) DE69100741T2 (ko)
ES (1) ES2062671T3 (ko)
FI (1) FI913495A (ko)
IE (1) IE912239A1 (ko)
NZ (1) NZ239052A (ko)
PT (1) PT98421A (ko)
ZA (1) ZA915128B (ko)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013028999A1 (en) 2011-08-24 2013-02-28 The Trustees Of Columbia University In The City Of New York Small molecule inducers of gdnf as potential new therapeutics for neuropsychiatric disorders
US11840541B2 (en) 2014-11-26 2023-12-12 The Trustees Of Columbia University In The City Of New York Opioid receptor modulators

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1184251A (en) * 1966-04-15 1970-03-11 American Cyanamid Co Oxazepines and Thiazepines
US4221714A (en) * 1979-08-03 1980-09-09 American Cyanamid Company 11-(1,2,3,6-Tetrahydro-substituted-4-pyridyl)-dibenz[b,f][1,4]oxazepines
US4798841A (en) * 1987-03-31 1989-01-17 Warner-Lambert Company Tetrahydropyridine oxime cholinergic agents and method of treatment
DE3726908A1 (de) * 1987-08-13 1989-02-23 Thomae Gmbh Dr K Neue kondensierte diazepinone, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE3735895A1 (de) * 1987-10-23 1989-05-03 Thomae Gmbh Dr K Kondensierte diazepinone, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel

Also Published As

Publication number Publication date
JPH04234384A (ja) 1992-08-24
AU8038591A (en) 1992-01-30
FI913495A (fi) 1992-01-25
ZA915128B (en) 1992-05-27
IE912239A1 (en) 1992-01-29
EP0468562B1 (en) 1993-12-08
ATE98240T1 (de) 1993-12-15
FI913495A0 (fi) 1991-07-19
DE69100741D1 (de) 1994-01-20
AU640799B2 (en) 1993-09-02
ES2062671T3 (es) 1994-12-16
NZ239052A (en) 1992-11-25
CA2046488A1 (en) 1992-01-25
PT98421A (pt) 1992-05-29
EP0468562A1 (en) 1992-01-29
DE69100741T2 (de) 1994-04-28

Similar Documents

Publication Publication Date Title
NO994582D0 (no) Fremgangsmaate for fremstilling av piperidinderivater
PT75471B (fr) Procede de preparation d'ethers tricycliques
DE69103206D1 (de) Neue Derivate des Aminopiperidins, Aminopyrrolidins und des Aminoperhydroazepins, Verfahren zur Herstellung und diese enthaltende Arzneimittel.
KR890000421A (ko) 치환된 인돌리논 유도체를 제조하는 향상된 방법
KR900006347A (ko) 살균성 플루오로퀴놀로닐 세펨
PL309874A1 (en) Novel derivatives of pyrrolocarbasol, method of obtaining them and pharmaceutical composition containing such derivatives
DE69206889D1 (de) Arylalkylpiperidine-4-yl)methyl]-2-alpha-3,4,5-tetrahydro-1-(2H)-acenaphthylene-1-Onederivate, ein Verfahren für ihre Herstellung und ihre Verwendung als Medikamente
KR920002595A (ko) 테트라히드로 피리디닐디벤즈 아제핀 유도체
KR930006003A (ko) 이미다졸릴메틸-피리딘류 화합물
DE69131057T2 (de) 3-[1,Thiazolidinylbutyl-4-piperazinyl]-1H-Indazole, Verfahren zu ihrer Herstellung und ihre Verwendung als Medikamente
DE3866292D1 (de) Piperazinylalkylpiperazindion-derivate, ihre verfahren zur herstellung und diese enthaltende pharmazeutische zusammenstellungen.
DE59206593D1 (de) Verwendung von 2-Iminothiazolidin-4-onderivaten als neuartige Arzneimittelwirkstoffe
DE69129790T2 (de) 5-Amino-5,6,7,8-Tetrahydrochinoline und verwandte Verbindungen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
AU551901B2 (en) Substituted thienobenzodiazepinones
DE69202594D1 (de) Zusammensetzung gegen Katarakt.
MX9601163A (es) Nuevos compuestos derivados de cromeno.
KR920002564A (ko) N-알킬 티아졸리딘 유도체
HU911895D0 (en) Process for producing (1-aryl-pyrrolidine-2yl)-methyl-piperazine derivatives and pharmaceutical prepartives containing these compounds
GR3019559T3 (en) 4-[4- or 6-(Trifluoromethyl-2-pyridinyl)]-1-piperazinyl-alkyl substituted lactams
KR860007263A (ko) 치환된 1,8-나프티리딘온의 제조방법
NO920041L (no) Tetrahydropyridinyldibenzazepin-derivater

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid